检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:邱艳艳[1] 王炎[1] 胡送娇[1] 刘培峰[2] 陈星竹[1] 梁波[1] 包益洁 段友容[2] 殷佩浩[1] 彭文[1] 李琦[1]
机构地区:[1]上海中医药大学附属普陀医院,上海200062 [2]上海市肿瘤研究所,上海200032
出 处:《中华中医药杂志》2014年第2期453-456,共4页China Journal of Traditional Chinese Medicine and Pharmacy
基 金:上海市普陀区科委创新重大项目(No.2011PTKW001);上海市科委引导项目(No.114119B3100);上海市卫生局中医处资助项目(No.2010Q L050B);上海市科委纳米专项(N o.11n m0504500);院级课题(No.2013GQ013Ⅰ;No.2013GQ002Ⅰ)~~
摘 要:目的:探讨蟾毒灵多级靶向纳米粒治疗裸鼠肠癌的作用。方法:建立裸鼠皮下移植性肠癌模型并随机分为如下6组:生理盐水(NS)组、蟾毒灵(Bufalin)组、聚乙二醇/聚丙交酯-乙交酯/聚赖氨酸(mPEG-PLGAPLL)纳米粒组(mPEG-PLGA-PLL NPs)、缬氨酸-精氨酸-甘氨酸-天冬氨酸-谷氨酸环肽(cRGD)修饰mPEGPLGAPLL纳米粒组(mPEG-PLGA-PLL-cRGD NPs)、载Bufalin的mPEG-PLGA-PLL纳米粒组(Bufalin-mPEG-PLGAPLL NPs)、载Bufalin的mPEG-PLGA-PLL-cRGD纳米粒组(Bufalin-mPEG-PLGA-PLL-cRGD NPs),经尾静脉给药。比较治疗后各组裸鼠的肿瘤生长情况、肿瘤坏死程度和荷瘤生存时间。结果:治疗后Bufalin组、Bufalin各纳米粒组瘤体均缩小,以经Bufalin-mPEG-PLGA-PLL-cRGD NPs组最为显著;Bufalin各纳米组荷瘤裸鼠平均荷瘤生存时间明显长于其他组(P<0.01);病理结果显示,Bufalin-mPEG-PLGA-PLL-cRGD NPs组肿瘤以重度坏死为主,肿瘤坏死程度显著重于其他各组(P<0.01)。结论:Bufalin多级靶向纳米粒以纳米剂型给药抗癌效果明显增强。Objective: To determine the targeting efficacy of Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles (Bufalin-mPEG-PLGA-PLL-cRGD NPs) in SW620 colorectal cancer-bearing mice. Methods: The mice were classified into 6 groups on the basis of the solutions they were administered: normal saline (NS) group, Bufalin solution group, mPEG-PLGA- PLL NPs group, mPEG-PLGA-PLL-cRGD NPs group, Bufalin-mPEG-PLGA-PLL NPs group, and Bufalin-mPEG-PLGA-PLL- cRGD NPs group, by injection through the tail vein every other day. After administration, we measured the tumor volume at predetermined intervals and calculated the inhibitory rate. Results: Bufalin-mPEG-PLGA-PLL-cRGD NPs could effectively target the tumor in vivo. The Bufalin-mPEG-PLGA-PLL-cRGD NPs were significantly more effective than other NPs in preventing tumor growth. This study supported the new paradigm for the application of Bufalin to treat colorectal cancer. Conclusion: The anti-cancer effect is greatly enhanced when given in Bufalin-mPEG-PLGA-PLL-cRGD NPs form.
分 类 号:R273[医药卫生—中西医结合]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15